Search results for: Precision Medicine
Filter search results
Economic Evaluation and Develop Medicines in the Development of Medicines
1 April 1988
…they give good value for money. Medicines have not been exempt from this process and there is increased emphasis on demonstrating additional benefit or social value from new medicines that…
New OHE Consulting Report: Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?
16 February 2017
…to identify the most suitable approach for assessing regenerative medicines, but rather to test whether regenerative medicines could fit into the existing pathway developed for conventional medicines. We suggest a…
Health and the Use of Medicines in Primary Care in Wales
1 November 2011
…their medicines allocations, although the reasons remain unclear. At the same time, however, Wales lags behind England in the uptake of new primary and secondary care medicines that have received…
A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
1 September 2021
Medicines for rare and ultra-rare conditions face distinct economic and ethical challenges compared to medicines for more common conditions. These challenges are implicitly acknowledged by the National Institute of Health…
What is the impact of Uniform Pricing, Indication-Based Pricing (IBP) and alternative commercial arrangements for new pharmaceuticals in the UK NHS?
19 November 2024
For the growing number of multi-indication medicines, challenges arise in assessing and paying for value across medicine indications with a uniform price (see our previous report and further publications for more context on the…
OHE Study Projecting UK Medicines Expenditure Extended to 2018
18 November 2013
The extended analysis is outlined in the slide presentation in this post. PharmacoEconomics recently published OHE’s study projecting medicines expenditure in the UK to 2015. The PPRS 2014 Heads of…
Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS
1 August 2018
This OHE Consulting Report reviews “Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS.” The project was funded by the ABPI. For the year 2015/16, the Treasury reported…
Science in Medicine: How Far Has It Advanced?
1 January 1993
…of science in medicine in the twentieth century. The examples have been chosen to illustrate different degrees of penetration of the scientific method in different fields of medicine. Finally, the…
Medicines and the Quality of Life
1 September 1982
…problem of evaluating the contribution of medicines to the quality of life. It… Previous studies concerned with the benefits of modern medicines have concentrated mainly on their economic consequences (Wells…